This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
Vnitrni Lekarstvi
Download PDF
Print
Journal Information
Journal Title
Vnitrni Lekarstvi
Publisher
SOLEN s.r.o.
ISSN
0042-773X
E-ISSN
1801-7592
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year
A+
A
B
C
2026
✓
2025
✓
2024
✓
2023
✓
2021/2022
✓
2020
✓
2019
✓
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Thiamine deficiency syndromes - case report and overview
Jiří Müller, Jaroslav Raděj, Lenka Valešová et al.
2026-10-2
Vol. 72
Issue 6
Pages 413-419
DOI:
10.36290/vnl.2026.075
Sequencing and combination of therapies in the cardiovascular-kidney-metabolic syndrome: GLP-1 RA, SGLT2 inhibitors, lipid-lowering drugs and mineralocorticoid receptor antagonists
Michal Dubský
2026-10-2
Vol. 72
Issue 6
Pages 388-394
DOI:
10.36290/vnl.2026.072
GLP-1 receptor agonists in obesity treatment: where we are today and what can we expect?
Dita Pichlerová
2026-10-2
Vol. 72
Issue 6
Pages 374-381
DOI:
10.36290/vnl.2026.070
Dyslipidemia in cardio-reno-metabolic syndrome
David Karásek
2026-10-2
Vol. 72
Issue 6
Pages 382-387
DOI:
10.36290/vnl.2026.071
Modern treatment of hereditary angioedema due to C1 inhibitor deficiency: from attack control to complete disease control
Roman Hakl, Jan Baroš, Jiří Litzman
2026-10-2
Vol. 72
Issue 6
Pages 396-400
DOI:
10.36290/vnl.2026.073
The role of SGLT2 inhibitors in outpatient cardiology practice
Petra Buděšínská
2026-10-2
Vol. 72
Issue 6
Pages 364-372
DOI:
10.36290/vnl.2026.069
Changes in diabetes care assessed from the number of HbA1c assays performed during COVID pandemic in Slovakia
Martin Jankovsky, Jozef Lacka, Viktor Oliver Rácz et al.
2026-10-2
Vol. 72
Issue 6
Pages E1-E5
DOI:
10.36290/vnl.2026.077
Aprocitentan - a dual endothelin receptor antagonist for the treatment of resistant arterial hypertension
Jitka Mlíková Seidlerová
2026-10-2
Vol. 72
Issue 6
Pages E16-E20
DOI:
10.36290/vnl.2026.079
Hematoncology treatment toxicity
Simona Pavúková, Roman Králik, Juraj Payer et al.
2026-10-2
Vol. 72
Issue 6
Pages E11-E15
DOI:
10.36290/vnl.2026.078
Cushing's syndrome: current view
Michal Kršek
2026-10-2
Vol. 72
Issue 6
Pages 402-411
DOI:
10.36290/vnl.2026.074
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 6, 2026 20:21